Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD-ON.

Pediatric pulmonology·2026
Same author

Respiratory Outcomes in Children With Neonatal Respiratory Distress Syndrome and Monoallelic ABCA3 Variants.

Pediatric pulmonology·2026
Same author

Indications, techniques, and safety of cryotherapy and cryobiopsy via flexible bronchoscopy in pediatric patients.

Annals of the American Thoracic Society·2026
Same author

BRD4 promotes endodermal cell fate during mammalian lung development.

JCI insight·2026
Same author

A Pediatric Patient With PCD and Broncholith Formation.

Pediatric pulmonology·2026
Same author

Hermansky-Pudlak Syndrome.

Clinics in chest medicine·2025
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
Same journal

Eisenmenger Syndrome: The Pulmonology Perspective.

Chest·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

Update on Diffuse Lung Disease in Children.

Timothy J Vece1, Lisa R Young2

  • 1Section of Pulmonology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.

Chest
|October 27, 2015
PubMed
Summary
This summary is machine-generated.

Children's interstitial lung disease comprises rare, diverse lung disorders affecting gas exchange. Recent advances improve understanding, diagnosis, and treatment of these serious pediatric conditions.

Keywords:
interstitial lung diseasepediatric pulmonologyrecent advances in chest medicine

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

52.8K
Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.7K

Related Experiment Videos

Last Updated: Mar 31, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

52.8K
Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.7K

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Respiratory Medicine

Background:

  • Diffuse lung diseases in children (DLD) encompass rare, heterogeneous conditions impacting pulmonary gas exchange.
  • Collectively, these DLDs contribute to substantial pediatric morbidity, mortality, and healthcare resource use.
  • Despite individual rarity, the collective impact of DLD necessitates focused research and clinical attention.

Purpose of the Study:

  • To review recent significant advancements in the understanding of pediatric diffuse lung diseases.
  • To summarize updated diagnostic approaches for children's interstitial lung disease.
  • To outline current and emerging treatment strategies for diffuse lung diseases in children.

Main Methods:

  • Comprehensive literature review of recent studies on pediatric diffuse lung diseases.
  • Analysis of genetic discoveries and their implications for DLD.
  • Evaluation of newly developed clinical practice guidelines for DLD management.

Main Results:

  • Significant progress has been made in identifying genetic underpinnings of various DLDs.
  • Clinical practice guidelines have been established, aiding standardized diagnosis and management.
  • Advances in understanding disease mechanisms are paving the way for targeted therapies.

Conclusions:

  • Recent breakthroughs enhance the comprehension of DLD pathophysiology.
  • Improved diagnostic tools and genetic insights are transforming patient care.
  • The field is evolving towards more personalized and effective treatment paradigms for children with diffuse lung diseases.